Pete Rizzo reported that Charles Schwab suggested an unspecified crackdown on AI data centers might be causing Bitcoin miners to redirect computing resources back to Bitcoin mining. However, no specific details, policy actions, or named Schwab officials were provided. The claim remains unverified and lacks identification of any miners who have made this shift. This could indicate a potential shift in computing resource allocation influenced by regulatory or operational changes in AI infrastructure.
Pete Rizzo's report on AI data center crackdowns and Bitcoin miners is presented here with Pluang's cryptocurrency market data for context. For readers following major cryptocurrencies on Pluang as of Nov 13, 2026 16:02 WIB: out of 50 priced assets, 13 rose and 36 fell. Notable figures include BAL at Rp16.297 (+11.14%), EOS at Rp12.649 (+8.13%), and BTC at Rp1.253.364.226 (-6.13%) with a typical hold time of 113 days and Pluang order activity showing 27% sell and 73% buy.
The Philippines solar energy market is projected to grow from 5.43 GW in 2026 to 23.35 GW by 2032, with a CAGR of 27.46%. Growth is fueled by declining costs of solar panels and installation, government-backed renewable energy auctions, and increasin...
Equinor ASA shares will trade ex-dividend on the Oslo Stock Exchange starting November 13, 2026, for the second quarter of 2026. The declared dividend amount is $0.39 per share, payable in USD. This means investors buying shares from this date will n...
China Eastern Airlines signed 23 procurement agreements worth $540 million with 15 suppliers from eight countries at the 9th China International Import Expo in Shanghai. The deals cover aircraft engines, aviation materials, jet fuel, and in-flight ca...
Eramet announced a €500 million share capital increase through a rights issue, offering 6 new shares for every 5 existing shares at €14.49 each. The proceeds will be used to reduce the company's debt and strengthen its balance sheet as part of a prev...
Pasithea Therapeutics announced positive Phase 1/1b results for PAS-004, showing significant reductions in cutaneous neurofibromas (cNF) size by up to 71% with continued treatment and early activity in plexiform neurofibromas (PN). The drug demonstra...
